The TFRI-MOHCCN Technology Development Awards provides funding to projects to develop additional profiling technologies that would generate data compatible with precision oncology and could be applied to a section of the MOHCCN Gold Cohort.
When autocomplete results are available use up and down arrows to review and enter to select.
A recent study by MOHCCN-funded researchers at BC Cancer is helping to accelerate precision medicine for cancer by shedding new light on why some patients with relapsed DLBCL respond well to standard-...
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...